{"id":"https://openalex.org/W35498375","doi":null,"title":"Development and characterization of darbepoetin alfa.","display_name":"Development and characterization of darbepoetin alfa.","publication_year":2002,"publication_date":"2002-10-01","ids":{"openalex":"https://openalex.org/W35498375","mag":"35498375","pmid":"https://pubmed.ncbi.nlm.nih.gov/12435169"},"language":"en","primary_location":{"id":"pmid:12435169","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12435169","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology (Williston Park, N.Y.)","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076128060","display_name":"Joan C. Egrie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joan C Egrie","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, California 91320-1799, USA. joane@amgen.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, California 91320-1799, USA. joane@amgen.com","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111990708","display_name":"Jeffrey K. Browne","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey K Browne","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.6877,"has_fulltext":false,"cited_by_count":48,"citation_normalized_percentile":{"value":0.84016907,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"16","issue":"10 Suppl 11","first_page":"13","last_page":"22"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/darbepoetin-alfa","display_name":"darbepoetin alfa","score":1.0},{"id":"https://openalex.org/keywords/recombinant-human-erythropoietin","display_name":"recombinant human erythropoietin","score":0.875},{"id":"https://openalex.org/keywords/hyperglycosylation","display_name":"hyperglycosylation","score":0.8610000014305115},{"id":"https://openalex.org/keywords/n-glycosylation","display_name":"N-glycosylation","score":0.7649999856948853},{"id":"https://openalex.org/keywords/sialic-acid","display_name":"sialic acid","score":0.9760000109672546},{"id":"https://openalex.org/keywords/circulating-half-life","display_name":"serum half-life","score":0.9670000076293945},{"id":"https://openalex.org/keywords/receptor-binding-affinity","display_name":"receptor binding affinity","score":0.7480000257492065},{"id":"https://openalex.org/keywords/anemia-treatment","display_name":"anemia treatment","score":0.75},{"id":"https://openalex.org/keywords/erythropoiesis-stimulating-agents","display_name":"erythropoiesis-stimulating agents","score":0.777999997138977}],"concepts":[{"id":"https://openalex.org/C2781404941","wikidata":"https://www.wikidata.org/wiki/Q2178381","display_name":"Darbepoetin alfa","level":3,"score":0.9664183855056763},{"id":"https://openalex.org/C2780115458","wikidata":"https://www.wikidata.org/wiki/Q419311","display_name":"Sialic acid","level":2,"score":0.800258219242096},{"id":"https://openalex.org/C2778534260","wikidata":"https://www.wikidata.org/wiki/Q218706","display_name":"Erythropoietin","level":2,"score":0.7677686214447021},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5665621757507324},{"id":"https://openalex.org/C2778977261","wikidata":"https://www.wikidata.org/wiki/Q11358","display_name":"Carbohydrate","level":2,"score":0.5631804466247559},{"id":"https://openalex.org/C2776164570","wikidata":"https://www.wikidata.org/wiki/Q5383794","display_name":"Epoetin alfa","level":3,"score":0.49906396865844727},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47307857871055603},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.47277024388313293},{"id":"https://openalex.org/C2777313579","wikidata":"https://www.wikidata.org/wiki/Q898365","display_name":"Glycosylation","level":2,"score":0.4466519355773926},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.4178241789340973},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4161539673805237},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39263176918029785},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3699381649494171},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3621017336845398},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34739136695861816},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27001869678497314},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2549257278442383},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068256","descriptor_name":"Darbepoetin alfa","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D021281","descriptor_name":"Quantitative Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12435169","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12435169","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology (Williston Park, N.Y.)","raw_type":"Journal Article"},{"id":"mag:35498375","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12435169","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W96072354","https://openalex.org/W269588983","https://openalex.org/W1484334243","https://openalex.org/W1493841569","https://openalex.org/W1541049769","https://openalex.org/W1549070022","https://openalex.org/W1565541955","https://openalex.org/W1570484367","https://openalex.org/W1573653133","https://openalex.org/W1573656797","https://openalex.org/W1584580474","https://openalex.org/W1595400617","https://openalex.org/W1604651284","https://openalex.org/W1966785697","https://openalex.org/W1974191492","https://openalex.org/W1978242698","https://openalex.org/W1981274345","https://openalex.org/W1981704185","https://openalex.org/W1996391942","https://openalex.org/W1999899046","https://openalex.org/W2000540313","https://openalex.org/W2013563801","https://openalex.org/W2017567201","https://openalex.org/W2029738096","https://openalex.org/W2038179113","https://openalex.org/W2039728906","https://openalex.org/W2043738725","https://openalex.org/W2065549220","https://openalex.org/W2068908743","https://openalex.org/W2077704585","https://openalex.org/W2077891756","https://openalex.org/W2103530688","https://openalex.org/W2108511043","https://openalex.org/W2122823145","https://openalex.org/W2167450157","https://openalex.org/W2278696640","https://openalex.org/W2315613377","https://openalex.org/W2333313938","https://openalex.org/W2749363897","https://openalex.org/W4231161631","https://openalex.org/W4235907762"],"related_works":["https://openalex.org/W2169177790","https://openalex.org/W7096465422","https://openalex.org/W2140152753","https://openalex.org/W2145908121","https://openalex.org/W1998152226","https://openalex.org/W1965078040","https://openalex.org/W2048802503","https://openalex.org/W2143201063","https://openalex.org/W126008903","https://openalex.org/W2078636555"],"abstract_inverted_index":{"Studies":[0],"on":[1],"human":[2,64,155],"erythropoietin":[3],"(EPO)":[4],"demonstrated":[5],"that":[6,44,50],"there":[7],"is":[8,107,150],"a":[9,56],"direct":[10],"relationship":[11,33],"between":[12],"the":[13,19,42,46,144],"sialic":[14,101],"acid-containing":[15,102],"carbohydrate":[16,47,84,103],"content":[17],"of":[18,160],"molecule":[20,57],"and":[21,25,117,136,162],"its":[22,35,99,165],"serum":[23,130],"half-life":[24],"in":[26,93,133,154,164],"vivo":[27,134],"biological":[28,60,146],"activity,":[29],"but":[30],"an":[31,113,126],"inverse":[32],"with":[34,58,122],"receptor-binding":[36],"affinity.":[37],"These":[38],"observations":[39],"led":[40],"to":[41,55,70,80,98,142],"hypothesis":[43],"increasing":[45],"content,":[48,104],"beyond":[49],"found":[51],"naturally,":[52],"would":[53],"lead":[54],"enhanced":[59],"activity.":[61],"Hyperglycosylated":[62],"recombinant":[63],"EPO":[65],"(rHuEPO)":[66],"analogs":[67],"were":[68],"developed":[69],"test":[71],"this":[72],"hypothesis.":[73],"Darbepoetin":[74,148],"alfa":[75,106,149],"(Aranesp),":[76],"which":[77],"was":[78],"engineered":[79],"contain":[81],"five":[82],"N-linked":[83],"chains":[85],"(two":[86],"more":[87],"than":[88],"rHuEPO),":[89],"has":[90,125],"been":[91],"evaluated":[92,153],"preclinical":[94],"animal":[95],"studies.":[96],"Due":[97],"increased":[100,114],"darbepoetin":[105],"biochemically":[108],"distinct":[109],"from":[110],"rHuEPO,":[111,123],"having":[112],"molecular":[115],"weight":[116],"greater":[118,132],"negative":[119],"charge.":[120],"Compared":[121],"it":[124],"approximate":[127],"threefold":[128],"longer":[129],"half-life,":[131],"potency,":[135],"can":[137],"be":[138],"administered":[139],"less":[140],"frequently":[141],"obtain":[143],"same":[145],"response.":[147],"currently":[151],"being":[152],"clinical":[156],"trials":[157],"for":[158],"treatment":[159],"anemia":[161],"reduction":[163],"incidence.":[166]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":6},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}